Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of solvates and compounds, applied in the field of compounds that regulate oxidoreductase indoleamine 2,3-dioxygenase, can solve problems such as different functions
Active Publication Date: 2017-08-01
FLEXUS BIOSCI
View PDF33 Cites 37 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
A homolog of IDO (IDO2) has been identified that shares 44% amino acid
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0366] Using general procedure B, use a mixture containing cis-(4-phenylcyclohexyl)methanamine (19 mg, 0.1 mmol), 4-cyanobenzoyl chloride (17 mg, 0.1 mmol) and NEt 3 (51 mg, 0.5 mmol) CH 2 Cl 2 (1 mL) was prepared. Purification using silica gel chromatography (10% to 30% EtOAc / hexanes) gave the desired product as a white solid. 1 H NMR (400MHz; CDCl 3 ):δ7.89-7.86(m,2H),7.74-7.71(m,2H),7.32-7.17(m,5H),6.32-6.30(m,1H),3.58(dd,J=7.7,6.0Hz ,2H),2.66-2.59(m,1H),2.06-2.00(m,1H),1.80-1.69(m,8H). m / z 319.3 (M+H + ).
[0370] Using general procedure B, use a mixture containing cis-(4-phenylcyclohexyl)methanamine (19 mg, 0.1 mmol), 3-cyanobenzoyl chloride (17 mg, 0.1 mmol) and NEt 3 (51 mg, 0.5 mmol) CH 2 Cl 2 (1 mL) was prepared. Purification using silica gel chromatography (10% to 30% EtOAc / hexanes) gave the desired product as a white solid. 1 H NMR (400MHz; CDCl 3 ):δ8.09-8.08(m,1H),8.04(dt,J=7.9,1.5Hz,1H),7.76(dt,J=7.7,1.3Hz,1H),7.56(t,J=7.8Hz, 1H), 7.32-7.17(m, 5H), 6.49-6.46(m, 1H), 3.58(dd, J=7.7, 6.0Hz, 2H), 2.66-2.59(m, 1H), 2.07-2.01(m, 1H), 1.80-1.68 (m, 8H). m / z 319.2 (M+H + ).
[0374] Using general procedure B, use a mixture containing cis-(4-phenylcyclohexyl)methanamine (19 mg, 0.1 mmol), 4-chlorobenzoyl chloride (19 mg, 0.1 mmol) and NEt 3 (51 mg, 0.5 mmol) CH 2 Cl 2(1 mL) was prepared. Purification using silica gel chromatography (0% to 20% EtOAc / Hexanes) gave the desired product as a white solid. 1 H NMR (400MHz; CDCl 3 ):δ7.73-7.69(m,2H),7.41-7.38(m,2H),7.31-7.23(m,4H),7.20-7.16(m,1H),3.55(dd,J=7.7,5.9Hz ,2H), 2.63-2.59(m,1H), 2.04-1.98(m,1H), 1.79-1.67(m,8H). m / z 328.2 (M+H + ).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
Compounds that modulate the oxidoreductase enzyme indoleamine 2,3- dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.
Description
[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Application Serial No. 62 / 075,678, filed November 5, 2014, which is hereby incorporated by reference in its entirety. [0003] Background of the invention [0004] Indoleamine 2,3-dioxygenase (IDO; also known as IDO1) is an IFN-γ target gene that plays a role in immune regulation. IDO is an oxidoreductase and is one of two enzymes that catalyze the first and rate-limiting step in the conversion of tryptophan to N-formyl-kynurenine. It exists as a 41 kD monomer found in several cell populations including immune cells, endothelial cells and fibroblasts. IDO is relatively well conserved between species, with mouse and human sharing 63% sequence identity at the amino acid level. Data derived from its crystal structure and site-directed mutagenesis show that both substrate binding and the relationship between substrate and iron-bound dioxygenase are necessary for activity. ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more